| abstract |
The present invention relates to a risperidone slow broadcast delivery system for treating medical conditions associated with delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive compulsive disorder, Tourette syndrome, and autism spectrum disorder. The slow broadcast delivery system includes a flowable composition containing risperidone, a metabolite or prodrug thereof, and an implant containing risperidone, a metabolite or prodrug thereof. The flowable composition can be injected into the tissue and then aggregates into a solid or gel-like monolithic implant. The flowable composition comprises a biodegradable thermoplastic polymer, an organic liquid and risperidone, its metabolite or prodrug. |